NCT05868538View on ClinicalTrials.gov

Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 1, 2023

Study Completion Date

March 15, 2023

Conditions
Behçet's Diseasecases
Interventions
DIAGNOSTIC_TEST

Serum calprotectin and IMA concentrations

Serum calprotectin and IMA concentrations were compared among active BD cases, inactive BD cases and control subjects.

Trial Locations (1)

Unknown

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT05868538 - Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease | Biotech Hunter | Biotech Hunter